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Introduction
Tobacco consumption, that leads to three million
deaths every year of which about one million occur in
developing countries is a social evil(1). Tobacco smoke
is a complex mixture of as many as 4700 individual
constituents including carcinogens, irritants, ciliotoxic
substances and poisonous gases. There is no dearth of
information about the health hazards to smokers. it has
been implicated as a major risk factor in a variety of
chronic diseases including cardiac, cerebrovascular,
malignant, respiratory and other diseases (2), Most of
the smoking related lung diseases (e.g. chronic obstruc-
tive lung disease and lung carcinoma) are dose depen-
dent. it is often the cumulative dose of smoking which
determines the risk. Parameters like pack-year (PY)
have been used to express exposure to tobacco smoke.
One PY implies one packet of cigarettes (or 20 gms.
tobacco) smoked each day over a course of one year (3).
In India the number of cigarettes and bidis per packet is
quite variable. A standard packet of cigarette and bidis
per packet is quite variable. A standard packet of
cigarette contains 10 numbers and a packet or bundle of
bidi contains 15-24 bidis. The weight of a bidi varies
widely in different brands. More importantly, the Indian
smokers often describe their smoking habit by the total
number of cigarettes/bidis smoked per day rather than
the number of packets (4). A smoking index (SI) to
quantify smoking exposure is therefore developed(5-7).
Smoking index is defined as the product of average
number of cigarettes (or bidis) smoked per day and the
total duration of smoking in years.
SI = Number of cigarettes/bidis smoked per day
x total duration in years.
Both the degree (number per day) and the
duration of smoking are given equal weightage. For
example, a subjectsmoking 10 cigarettes (or bidis) per
day for one year, and another smoking one cigarette
(or bidi) per day for ten years will have SI of 10. Both
these individuals are considered to be at equal risk.
Tobacco is also consumed by various other meth-
ods and these include hookahs (water pipe), Chutta
(cheroot smoked with the lighted end in the mouth),
chilums (clay pipes) and snuff, as well as chewing. As a
result, tobacco related cancers affect the mouth, phar-
ynx, larynx and oesophagus in addition to lung (8,9)
Different brands of cigarette and bidi smoke show little
difference in total particulate matter (TPM) and mean
 nicotine levels (8). Defining cumulative exposure in
terms of TPM rather than by tobacco consumption will be
fallacious since the chemical constituents may differ
widely with the method of analysis from different labora-
tories and brand of cigarette/bidi. Smoking habit can be
classified as mild (SI<100), moderate (SI 101-300) and
heavy (Sl>300) using the smoking index (3). It had been
observed that the prevalence of lung cancerand chronic
obstructive lung disease is more in heavy smokers
compared to mild smokers (6,10).
Pulmonary physiological abnormalities such as
bronchial hyperreactivity and abnormal spirometric
measurements are also severe in subjects with high
smoking index (11).
Experimental, clinical and epidemiological stud-
ies have clearly established a relationship between
cigarette smoking and a wide range of diseases (12).
Not only is smoking directly responsible for the cancer
of the lung and other site, but is also responsible for
increased morbidity and mortality from other
non-neoplastic respiratory diseases such as chronic
bronchitis emphysema syndrome, cor pulmonale and
respiratory infections.Tobacco smoke contains a
large number of tumourigenic agents (carcinogens) that
include benzo(a) pyrine, aza-arenes, N-nitrosamines,
aromatic amines, aldehydes and inorganic compounds.
As a result, tobacco is classified as a carcinogen (13).
Various studies had clearly demonstrated that nicotine is
an addictive drug and nicotine controls smoker’s behaviour
in such a way that reducing or suppressing tobacco
consumption leads to a withdrawal syndrome
characterised by irritability, difficulty in concentrating.
cognitive impairments and weight gain (14). U.S. Sur-
geon General’s Report on Smoking and Health has
therefore, rightly concluded that cigarette smoking is the
largest avoidable cause of death and disability in United
States (15). Nearly a third of all cancers that occur in
lndia are attributable to tobacco use (16). In India, until
recently cancer of the oral cavity was the most common
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lesion because of widespread tobacco chewing habit.
However, there is a gradual change over from tobacco
chewing to tobacco smoking and this may increase the
incidence of lung cancer in India (17). A national survey
conducted by the National Sample Survey organisation
in 1987/88 had revealed that average tobacco usage
prevalence was 35% for men and 12% for women (18).
The mortality rate due to all causes among tobacco users
is 1.4 to 1.6 times higher than that in non-users and it had
been estimated that approximately approximate 80,000 death could
be attributed to tobacco usage (19). It had also been
computed recently that a minimum of Rs.10,000/
- was required for the management of each tobacco
related cancer case. It does not include the cost of
services provided by the Government through various
health agencies and also does not include the cost of non-
productivity owing to the absence of the individuals from
the worksite. Thus, the management of the total number
of tobacco related cancer cases will cost the exchequer
a sum several times higher than the total revenue
generated by tobacco (17). Annual incidence of tobacco
related cancer cases (17) in India is given in the Table.
TABLE
Annual incidence of tobacco related cancer cases
in India. Estimated burden in 1992.
Male Female Total
Estimated populaiion (millions) 450 412 862
Crude rate/100,000 70 80
Total new cancer cases
(all forms) in 1992 315,000 329,000 644,600
New cases related to tobacco
habit:-
Pharynx & larynx
Lung
Others
Total
Proportion of tobacco
related cancers
(Source: Reference 17)
36,000 27,000 63,000
49,000 10,600 59,800
23,700 16,500 40,200
27,800 5,100 32,900
15,000 7,200 22,200
1,51,700 66,400 218,100
48% 20%0 34%
Effect of smoking on Pulmonary Anatomy and
Physiology
Structural Changes: There is increasedmucus forma-
tion due to hypertrophy and hyperplasia of mucous
glands of the large airways. This results in increased
sputum production. It is mainly the tar content of
cigarettes which affects the phlegm (20). In the small
airways, there is inflammation, goblet cell hyperplasia
and intraluminal mucous formation which result in air-
ways closure. This may be the forerunner of chronic
obstructive lung disease. Experimental and radioisotopic
studies have demonstrated that tobacco smoke dam-
ages the tight junction of airway epithelium and facilitates
epithelial permeability (21,22) and this abnormal epithe-
lial permeability can be reversed after cessation of
smoking (21). The enhanced absorption of inhalant
toxins and other aerosols resulting from increased per-
meabi i i ty  leads to exaggerated bronchia l
hyperresponsiveness to inhaled methacholine in both
symptomatic and asymptomatic smokers (23,24).
Functional Changes: The earliest functional changes
that may occur due to tobacco smoking result from small
airways disease. Peripheral airways are the site of
increased resistance in obstructive lung disease and
peripheral airways obstruction is associated with a chronic
inflammatory process in the wall and Iumen of the
airways(25). Various tests that include frequency depen-
denceof compliance, residual volume, oxygen saturation
on exercise, closing volume; and tests based on the
forced expiratory manoeuvre are available for screening
of small airways obstruction (26). However, tests based
on forced expiratory manoeuvre such as mean flow rates
at 25-75% vital capacity (FMF25-75%), instantaneous flow
rates at 50% (VEmax 50%) and 75% (VEmax 75%), flow
rates with and without helium breathing, volume of
isoflow and mean transit time appear to be the best of
these testsEven though FMF25-75% is a simple test, it has
high coefficient of variation which is true for VEmax 50%
and VEmax 75%.Small airway dysfunction can occur
even in asymptomatic smokers. In advanced cases,
expiratory flow rates are reduced and the forced expira-
tory volume in one second (FEV1) can be used as a
predictor of development of obstructive airway disease.
A relatively bw FEV1 compared to the predictedvalue by
middle age and a faster rate of its fall with age indicate
that he/she may be a strong candidate to develop severe
functional impairment. The fall in FEV1 can be signifi-
cantly arrested by discontinuation of smoking. Even if
smoking is stopped at the age of 40 years, the rate of
FEV, fall in ex-smokers becomes similar to that in non-
smokers (27).
Chronic Bronchitis and Emphysema: It is now well
establishedthat chronic bronchitis and emphysema are
smoking related diseases (28-31). As the pattern of
smoking in women approaches that in men (in the West)
the incidence of the disease in the females rises and may
equal the male incidence in the near future.
Tobacco smoking is the most important risk factor
associated with chronic bronchitis and emphysema(28).
Tobacco smoke attracts alveolar macrophages (AM) and
they cluster around the terminal bronchioles. Alveolar
macrophages activated bytobacco smoke release neu-
trophil chemotactic factors such as leukotriene B4
(LTB4), complement components (C5a) and neutrophil
chemotactic factor. Thus circulating neutrophils from the,
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blood stream are attracted to the site where AMs have
already clustered around the terminal bronchioles. To-
bacco smoke causesactivation of neutrophils resulting in
release of human neutrophil elastase (HNE). HNE is
capable of lysing elastin, collagen, proteoglycan,
fibronectin and laminin which form the interstitium of
lung. In a healthy individual, HNE is inactivated by alpha-
1 antitrypsin which is produced in the liver. The molecular
weight of alpha-1 antitrypsin is 52000 kilodalton (KD) and
this molecular size enables alpha-1 antitrypsin to migrate
to epithelial lining fluid of lung from blood. The binding
of alpha-1 antitrypsin with HNE results in inactivation of
HNE.
An active methionine residue present in alpha-1
antitrypsin molecule is essential for neutralization of
HNE. Oxidants present in smoke oxidizes methionine,
thus preventing the binding and inactivatan of HNE. In
addition oxidants released by activated neutrophiis are
also capable of oxidizing alpha 1 - antitrypsin. Thus
tobacco smoke, in. addition to increasing the HNE
burden in the lower respiratory tract, causes inactiva-
tion of protein alpha-1 antitrypsin which is essential for
body’s defense against elastases. This results in
unopposed action of HNE on lung tissue leading to
destructive changes (32).
It had been observed in a study of natural history
of chronic bronchitis and emphysema that airflow
obstruction developed in 10% of ex-smokers, 12%
moderate smokers (average upto 15 cigarettes per
day) and 26% heavy smokers (average over 15 ciga-
rettes per day) (33). Life long non-smokers do not develop
airflow obstruction unless other factors contribute to
airflow obstruction. This study suggested that two con-
trasting groupscould beidentified, viz., the “susceptibles”
who in their lifetime might become disabled by obstruc-
tive disease if they smoke and the : “non-susceptibles”
who would not, whether they smoke or not (33). Cur-
rently, no test is available to differentiate thesusc ptible
minority” of smokers from the “non-susceptibles”. Re-
search should be directed to identify the “susceptible
smokers” who develop airflow obstruction due to smok-
ing.
The prevalence of chronic bronchitis is high among
lndian smokers (34-39). In Bombay, cough, dyspnoea or
both was observed among 39% of smokers and 13% of
non-smokers (39), and studies in North India had re-
vealed a high prevalence of chronic bronchitis and ob-
structive airway diseases (38,40,41) among smokers.
In urban Chandigarh and rural Mullapur in North India,
chronic bronchitis was diagnosed in 9.9% and 16.4% of
male smokers and in only 0.9% and 4.1% of non-smokers
(40).
Smoking and Airway obstruction: Regular cigarette
smoking increases phlegm production and airway ob-
struction and in susceptible smokers airway obstruction is
often irreversible (20). Even the response to treatment
for asthma is poorer among smokers than non-smok-
ers(42). A steep fall in the forced expiratory volume was
 shown among smokers with bronchial hyperreactivity
(43).
Exposure to Environmental Tobacco Smoke
Studies in Western countries have shown that
exposure to environmental tobacco smoke (ETS), or
passive smoking, also known as secondary or involuntary
smoking, is associated with impaired lung function,
increased rates of respiratory illness and chronic airway
diseases (44-46). It is estimated in 1986 apart from
35000-40000 annual deaths due to ischemic heart dis-
ease (47), ETS has been associated with variety of lung
diseases including lung cancer in 3000 patients (48). In
1990, Environmental Protection Agency published a
similar report (49). In asthmatic children, exposure to
ETS leads to increased severity of the disease (50). In
US, the National Research Council estimated an in-
creased risk from lung cancer of 34% for non-smoking
spousesof smokerscompared with non-smoking spouses
of non-smokers (48). It had also been observed from
Japan that standardized mortality ratios for lung cancer
in non-smoking Japanese women were increased in,
direct proportion to the amount smoked by their hus-
bands (51). These studies suggest that smoking is a
public health hazard with the potential to injure innocent
non-smokers exposed to environmental tobacco smok-
ers.
ETS have adverse effects on the treatment of
asthmatic patients (52). The worsening of airway ob-
struction is due to the reflex stimulation of parasympa-
thetic pathways by the smoke particles, Asthmatics,
charactarized by increased airway responsiveness to
various stimuli react abnormally to particulate matters
(53). Even in nonasthmatic patients, cigarette and bidi
smokiig are known to increase bronchial responsiveness
(54-55). Exposure to ETS may also increase airway
responsiveness (56).
In adults, respiratory symptoms, chronic bronchi-
tis and asthma attacks are more common in nonsmokers
exposed passively to tobacco smoke as compared to
those who are not exposed (57). There is an increased
bronchial reactivity to inhaled bronchoconstrictor aero-
sols in wives of smokers presumably due to increased
epithelial permeability. This would imply increased
absorption of most tobacco combustion byproducts in-
haled by these subjects in the company of smokers. Peak
expiratory flow rate was significantly lower in passive
women smokers and the reduction was found to be in
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proportion to the amount of smoking (58). Environmental
tobacco smoke along with other air pollutants may be
responsible for the high prevalenceof chronic respiratory
disease and cor-pulmonale in non-smoking subjects
especially women in ourcountry (59).
Parental smoking exacerbates respiratory dis-
eases in children. The occurrence of cough and cold
and the risk of hospitalization for respiratory illness had
been shown to be higher among children when one or
both parents were smokers (60,61). Maternal smoking
has been shown to be a leading cause of paediatric
deaths resulting from low birth weight, short gestation,
respiratory distress syndrome and sudden infant death
syndrome (48). There is twice the risk of pneumonia
and bronchitis amongst children of smokers during first
year of life (43). Heavy smoking during pregnancy may
have a direct effect on the offspring’s subsequent lung
function and a relationship was suggested between
early childhood bronchitis or pneumonia and impair-
ment of lung function in later childhood with maternal
smoking habit (62). Furthermore, asthmatic children
of mothers who smoked had lower expiratory flow
rates and more emergency room visits than those with
non-smoking mothers (49,63). These observations
emphasize the adverse effects of exposure to ETS in
children.
Effect on Exercise Tolerance
Smoking reduces the exercise tolerance even in
asymptomatic individuals. Even a single cigarette or
bidi smoking has been shown to increase airway
resistance (64). Exercise tolerance is further reduced
in bronchitic patients with continued smoking due to
high camoxyhemoglobin level (65,66).
Other Effects
lncidence of respiratory infections especially pneu-
monia and influenza is enhanced in smokers (67). Post
operative respiratory complications are also more in
smokers (68,69).
It had been established that there was an interac-
tion between occupational carcinogens such as asbestos
and radon and smoking (70). In comparison with non-
smokers in general population, the risk of lung cancer
deaths in asbestos workers who smoked was increased
by 90 - fold (71). A multiplicative interaction between
smoking and radon also been seen in uranium workers
(72). Since radon is a ubiquitous indoorair pollutant (73).
smokers are at particularly high risk for developing
cancers from indoor radon (72). Smoking has also
synergistic effect with certain occupational exposures,
like coal mine dust, grain or cotton dust, in producing
chronic bronchitis and airways obstruction. Airways ob-
struction is found to be significantly more in smoking
Workers in silica industry (74-76).Therefore, smoking is
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a powerful risk factor which increases the risk not only of
lung cancer but also airway obstruction associated with
occupational exposure.
Medical Profession’s Role
Even though the ill effects of tobacco smoke to
human race is scientifically well established, the eradi-
cation of this pandemic, tabacosis, from the world was
not possible because of the commercial and political
power of tobacco industry. In India one million mar-
ginal farmers and five million farm workers are involved
in tobacco cultivation and processing. Tobacco culti-
vation does not require intensive irrigation and the leaf
growing costs are the lowest in India. As a result
 tobacco cultivation is popular in Karnataka and Andhra
Pradesh. In addition to depriving the farmers of their
livelihood, the income generated to the coffers of
Government by the tobacco industry stands in the way
of our efforts to eradicate this preventable malady.
India is the world’s third largest grower of tobacco and the
earning per hectare is from Rs. 15,000 to 30,000 com-
pared to Rs. 6,000 from non-tobacco crop. Cigarettes
contribute to 90% of tobacco revenue and no doubt, it
is good for farmer, good for revenue through exports, but
is bad for nation’s health. The impact of health hazards
of tobacco as discussed in newspapers seems to have
hardly any long lasting effect. Do we know our right to
breathe air that is free of tobacco smoke?
Medicine is not a Science but a learned profes-
sion charged with the obligation to apply them for the
benefit of mankind. Medicine is defined as a human
activity undertaken for the benefit of others whether in
the area of public health, statistical comparison, or in
the care of the individual (77). It is the foremost duty
of every person engaged in the profession of health
care delivery system to boldly expose the bare facts
without consideration of money, fame or credit.
The statutory warning on a cigaretee pack ap-
pears to have a low impact. Although every cigarette
package has the statutory warning printed, the same
appears at the comer of huge hoarding (in barely
visible letters) and the advertisements from the to-
bacco industry in the media are too tempting for
everybody in general, and for teenagers in particular.
Therefore, such warning remains inconsequential. A
survey in USA involving chronic smokers had revealed
that 70% were unable to identify the specific theme of
even one of the four surgeon general’s warnings on
cigarette packages, despite adequate opportunity for
exposure to such a warning (78). A one-pack-per day
(10 cigarettes per day) smoker is theoretically exposed to
the ‘warning’ 3650 times per year. These data originate
from societies with much higher literacy rates and much
easier accessibility to health information as compared to
182
those found in our set-up. No wonder then that the real
state of affairs in developing countries is expected to be
still worse and more saddening, where such warnings are
unlikely to have any impact on the health behaviour of
those using these products, as consumers, continue to
remain to a large extent not warned at all.
Instead of giving such warning, it is better to
increase the tax on cigarettes. Increasing the price of
cigarettes may decrease tobacco consumption (78).
This would help in two ways: to decrease smoking
habit and to generate revenue for potential use in
smoking prevention and health promotion efforts such
as health education, stop-smoking campaigns, re-
search into tobacco related diseases and prevention of
tabacosis. These efforts will certainly pay back ben-
efits in the form of improved health and reduce medical
care expenditure for the individual, the family, the
society and ultimately the nation at large. In order to
initiate a preventive programme, at least the hospitals
should be made a smoke-free environment.
What is the most important health problem to-
day? Is it human immunodeficiency virus (HIV) dis-
ease or tobacco-related disease? Even though to-
bacco abuse is the leading preventable cause of death
of mankind, political leaders and scientific community
have failed in their duties to provide adequate attention
to this alarming problem compared to those devoted to
HIV disease.
On a worldwide scale, tobacco consumption is
increasing by 2.1% per annum. Tobacco consumption
is increasing by about 3-4% per annum in developing
countries while it is decreasing by 0.2% per annum in
developed countries (79). Per capita cigarette con-
sumption in developing countries has risen on an average
by over 70% during the last 25 years and going by current
trends WHO estimates that there will be about seven
million deaths a year from tobacco in the developing,
countries within the next two or three decades (79). In the
developed countries, at least two million deaths a year
(20% of all deaths) can be attributable to smoking during
the same period (79). In the United States, there is a
decline in smoking prevalence and was found to be linear
across most socio-demographic groups. Smoking preva-
lence which was 50.2% in men and 31.9% in women in
1965 had declined to 31.7% in men and 26.8% in women
in 1985. Smoking prevalence was thus found to decrease
at a rate of 0.84% per year among males and 0.21% per
yearamong females (4880). A World Health Organiza-
tion expert panel has estimated that three million people
die every year because of tobacco use (1). The panel
predicts that if current smoking patterns continue, the toll
will increase to 10 million deaths a year by 2025. This
means that half a billion people now living - 10% of the
world’s population - could ultimately die of tobacco use
LUNG lNDlA (1994) XII, NO.4 (P.178-185)
(81,82). “Smoking represents the most extensively
documented cause of disease ever investigated in the
history of biomedical research” (83). The United States
Office on Smoking and Health’s bibliographical database
contains more than 50000 citations from biomedical
publications, summarized in more than 8000 pages in 21
 reports from the surgeon general. The BMJ Publications
Group has launched a new journal - “Tobacco ControI” in
March 1992 in time for the eighth world conference on
tobacco and health in Buenos Aires(84). As the control of
an infectious disease requires an understanding of the
causative agent, the vector, the host, and the environ-
ment in which transmission occurs, the same principles
apply to the control of tobacco abuse (85). Therefore,
tobacco control involves much more than the effects of
smoking on health. The journal will pay attention to the
host, publishing epidemiological and behavioral research
on tobacco use, and will analyze the environment in
which tobacco is used. The impact of tobacco on the
environment - for example on public health, economy,
and political processes - will be considered, as well as
the impact of the environment on tobacco. Programmes
and policies that discourage tobacco consumption are
an important part of that environment, and publishing
evaluations of these interventions will be a priori for
the new journal. Similarly, it will publish survey re-
search on public beliefs, opinions, and attitudes related
to tobacco (84)
Transnational tobacco companies - based
predominatly in the United States and Britain - are
aggressively marketing their products in the develop-
ing world (86-90) as their home markets shrink. A
major goal of the journal will be to report on the
activities of the developing world.
Will we be able to control this social evil? It is
suggested that social evils like alcoholism, commercial
sex and tobacco abuse can be controlled by commu-
nity and religious participation.
Smoking is one of the important threats to the
medical men since health risks from smoking are
abundant. The prevention of smoking demands a
political action because it is probably the largest single
preventable cause of ill health in the world. A conflict of
interest between health professionals and tobacco
industry is evident and a coexistence is not possible
between these two establishments. Why should then
the people suffer unnecessarily? Who is to tell the
politicians about the sufferings, tragedies, miseries and
economic tosses caused through smoking? Who is to
narrate the enormous magnitude of smoking related
problems? Who will make them realize the gravity of the
greatest epidemic of the present time arising out of abuse
of tobacco?Who will reveal the medical facts that 5% of
all deaths are caused by smoking? It is the duty of doctors
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as well as the health profession to act immediately. The
prevalence of smoking in doctors, teachers and medical
students (91-98) is quite alarming, and is the same as
that in the general population and they themselves need
a cleansing operation.
7. Jindal SK, Malik SK and Datta BN. Lung cancer in Northern lndia
in relation to age, sex and smoking habits. Europ J. Resp. Dis.
1987: 70: 23-18.
8.
Doctors must realize that their contribution does
not end with health education and disease manage-
ment. Their duty towards community is extended as
opinion makers of the society and of providers of
healthy atmosphere. A national coalition of concerned
physicians, teachers, religious leaders and opinion
makers is suggested (99) to bring about fundamental
changes to curtail the tobacco cultivation and
promotion and to prevent the epidemic of tobacco
related cancers, obstructive respiratory diseases and
cardiovascular disorders..
9.
10.
11.
12.
Pakhale SS, Jayant K. and Sanghvi LD. Chemical constituents
of tobacco smoke in relation to habits prevalent in lndia. In: R.
Viswanathan (Ed.) Smoking and Health. Ind J. Chest Dis. and
Alli. Sci. (Special No.) 1982 : 36-43.
Boyton R: Tobacco in India. Br. Med J 1990; 3 0: 8.
Malik SK. Tobacco smoking, product preference and chronic
bronchitis, ln : R. Viswanathan (Ed). Smoking and Health. lnd.
J. Chest Dis. and Alli. Sci. (Special No.) 1982: 83-90.
Jindal SK, Srinivasan G. and Malik SK. Airway response to
bronchoconstrictor aerosol (methacholine) in bidi and cigarette
  smokers(Abst). Proceedings of XV lnternational Conference
on Tuberculosis and Respiratory Diseases of IUATLD, Lahore;
Pakistan Dec 1987: 10-13.
13.
Many health professionals are afraid of getting
involved in such a process considering that exerting
political pressure is below dignity and is a distasteful
act. But in such a situation, our battle will be lost by
default. We must gather courage; and fortunately, we
have with us some major international voluntary health
organizations who are actively involved in exercising
political pressure. That makes our case more strong
but that gives us doctors a little jerk too, to realize our
duty as doctors towards suffering humanity (2). With
concerted efforts, the environment can be made to-
bacco-free; of course with the help of politicians and
the Government. After all, politicians are also reason-
able people, they are also open to arguments and
pressure which are based purely on medical facts and
meant solely for the community well being. They can
be made to realize the danger to the community from
smoke and the benefits of eradication of this social evil.
The day is not far when they will stand up, admit their
right to serve, realize their responsibility and perform
graciously their national duty and. help the medical
profession in creating a tobacco-free atmosphere for
every citizen of the universe.
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